Your Article Summary
Recent Research Supports the Importance of Starting Treatment Early in Patients with Multiple Sclerosis
BayNews International, 09/18/09
Findings from several clinical trials presented at the 25th Congress of the European Committee for Treatment and Research in Multiple Sclerosis underline the importance of recognizing the impact of hidden symptoms in patients with multiple sclerosis, and to therefore consider the importance of initiating treatment early.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09
Bioequivalence of two film-coated tablets of imatinib mesylate 400 mg: A randomized, open-label, single-dose, fasting, two-period, two-sequence crossover comparison in healthy male South American volunteers
Clinical Therapeutics, 12/01/09
Directly observed antiretroviral therapy: a systematic review and meta-analysis of randomised clinical trials
The Lancet - Early Online Publication, 12/01/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Allos Therapeutics Announces Issuance of U.S. Patent for FOLOTYN
Allos Therapeutics, 12/01/09
New Class of Platinum-Based Anti-Tumor Drugs, Bisplatinates, Demonstrates Potent Anti-Tumor Activity and Ability to Overcome Resistance to Currently Available Platinum-Based Agents
Cell Therapeutics, 12/01/09
Bayer Starts Phase III Trial with Florbetaben
BayNews International, 12/01/09
Article Search
Sponsor


See Latest Articles


